Texas A&M University Libraries
Index
Search form
EDIT MY PROFILE
Home
People
Organizations
Research
About
EE459 Is Adding Ribociclib to Fulvestrant Cost-Effective in Treating Post-Menopausal Women with HR+/ HER2- Advanced Breast Cancer - a US Payer Perspective Cost-Utility Analysis
Academic Article
Overview
Identity
Additional Document Info
Other
View All
Overview
authors
Zhong, Lixian
published proceedings
Value in Health
author list (cited authors)
Berrios, K., Burum, A., Jeong, E., & Zhong, L.
citation count
0
complete list of authors
Berrios, K||Burum, A||Jeong, E||Zhong, L
publication date
January 2022
publisher
Elsevier
Publisher
published in
Value in Health
Journal
Identity
Digital Object Identifier (DOI)
10.1016/j.jval.2022.04.707
Additional Document Info
start page
s425
end page
S425
volume
25
issue
7
Other
URL
http://dx.doi.org/10.1016/j.jval.2022.04.707